Table 3 Disease characteristics of multifocal patients by symptoms and by signs at the CIS
Multifocal | Multifocal by symptoms | Multifocal by signs | p-value | |
|---|---|---|---|---|
N | 222 | 122 | 100 | |
Sex – % of females | 76% | 77% | 74% | 0.6389† |
Age, median (quartiles) | 31 (25–37) | 30.5 (25–36) | 31 (25–38) | 0.7919‡ |
Steroid treatment – % | 70% | 72% | 67% | 0.4632† |
EDSS (screening), median (quartiles) | 2 1.5–2.5 | 2 1.5–2.5 | 2 1.5–2.5 | 0.9598‡ |
CSF positive of samples taken – % | 118/138 86% (53%) | 62/70 89% (51%) | 56/68 82% (56%) | 0.3405† |
Number of T2 lesions, median (quartiles) | 21 (8–41) | 19.5 (8–47) | 22.5 (9–40) | 0.9130‡ |
At least one Gd-enhancing lesion – % | 42% | 45% | 39% | 0.3376† |
At least one T1 hypointense lesion – % | 73% | 71% | 74% | 0.7627† |